News Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:12 2025-12-12 am EST			5-day change	1st Jan Change
80.00 ^GBX	0.00%		+8.11%	+8.84%

Nov. 04	Arecor Gains US, European Patents for Insulin Product Formulations, Intellectual Property	MT
Nov. 04	Arecor Therapeutics plc Enhances Ip Coverage for AT278 and Oral Delivery Technology	CI

Arecor Gains US, European Patents for Insulin Product Formulations, Intellectual Property	Nov. 04	MT
Arecor Therapeutics plc Enhances Ip Coverage for AT278 and Oral Delivery Technology	Nov. 04	CI
Arecor Therapeutics plc Announces Board Changes, Effective 29 September 2025	Sep. 29	CI
Seeing Machines loss narrows; Hansard profit falls	Sep. 25	AN
EARNINGS: Seeing machine loss narrows; Hansard profit falls	Sep. 25	AN
European stocks fade ahead of US data	Sep. 25	AN
AIM WINNERS & LOSERS: Proteome Sciences loss narrows but revenue falls	Sep. 25	AN
Arecor Signs New Co-Development, Royalty Financing Deals	Sep. 25	MT
Arecor Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2025	Sep. 25	CI
Arecor Therapeutics plc Signs Co-Development Agreement with Sequel Med Tech LLC	Sep. 25	CI
Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln	Sep. 25	RE
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292	Sep. 25	AQ
Earnings Flash (AREC.L) Arecor Therapeutics Reports H1 Revenue GBP2.0M	Sep. 25	MT
Gem Resources raises funds; Afentra Angolan progress	Sep. 04	AN
Arecor Receives Positive US FDA Feedback for Rapid-acting Insulin Study	Sep. 04	MT
Fulcrum sells Uranium stakes, Bluebird eyes Bitcoin	Jul. 14	AN
Arecor Establishes New Scientific Advisory Board	Jul. 14	CI
Arecor Therapeutics plc Announces Alan Smith to Retire from its Board, Effective 2 June 2025	Jun. 02	CI
Arecor Therapeutics plc - Special Call	May. 26
Arecor shares climb 18% on collaboration with Skye Bioscience	May. 19	AN
Arecor Partners with Skye Bioscience to Enhance Obesity Drug Formulation	May. 19	MT
Skye Bioscience, Inc. Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab	May. 19	CI
Big Technologies names new CEO; Van Elle's signs deal	May. 08	AN
Arecor Sells Non-Ogluo Tetris Pharma Product Rights to Aspire Pharma	May. 08	MT
Arecor Therapeutics Sells Rights To Non-Ogluo Products	May. 08	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Filters